Safety of rosuvastatin
- 1 October 2004
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 94 (7), 882-888
- https://doi.org/10.1016/j.amjcard.2004.06.049
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Rosuvastatin-Induced Arrest in Progression of Renal DiseaseJMIR AI, 2004
- European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)European Heart Journal, 2003
- Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemiaAmerican Heart Journal, 2002
- ACC/AHA/NHLBI clinical advisory on the use and safety of statinsJournal of the American College of Cardiology, 2002
- Cerivastatin and Reports of Fatal RhabdomyolysisNew England Journal of Medicine, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- A Comparison of Simvastatin and Atorvastatin up to Maximal Recommended Doses in a Large Multicenter Randomized Clinical TrialCurrent Medical Research and Opinion, 2001
- Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: The Pivotal Placebo-Controlled Clinical TrialJournal of International Medical Research, 2000
- Drug Treatment of Lipid DisordersNew England Journal of Medicine, 1999
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976